WA-SPIE
11.1.2023 19:04:37 CET | Business Wire | Press release
The Awards Committee of SPIE, the international society for optics and photonics, today announced the recipients of its prestigious annual awards. Honoring transformative advancements in a variety of professional areas — including medicine, astronomy, lithography, optical metrology, optical design, and community leadership — the Society's awards recognize technical accomplishments as well as committed service to SPIE and support of its organizational mission.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230110005929/en/
Graham Reed is the 2023 recipient of the SPIE Gold Medal. (Photo: Business Wire)
SPIE Gold Medal: Graham T. Reed
For sustained and ongoing leadership in the silicon photonics field, particularly in the area of silicon photonics modulators, mid-IR silicon photonics, and integrated lidar.
SPIE President's Award: Patrick Meyrueis
For bringing together the European optics and photonics community, for encouraging students toward leadership activities, and for commitment to the Society in launching SPIE Photonics Europe.
SPIE Directors' Award: John Greivenkamp
A posthumous recognition, for longstanding service and leadership, by generously giving time, energy, enthusiasm, and wisdom to improve the Society and its educational impact on the global photonics community.
SPIE Mozi Award: Burn J. Lin
For great scientific achievements in immersion lithography for semiconductor manufacturing.
SPIE Britton Chance Award in Biomedical Optics: David Benaron
For the development of technologies and the founding and co-founding of companies utilizing biomedical optics that advanced the fields of medicine and medical technology.
SPIE Biophotonics Technology Innovator Award: Wei Min
For innovative work in stimulated Raman scattering microscopy, and for creating a new field of biophotonics.
SPIE Rudolf and Hilda Kingslake Award in Optical Design: Wilhelm Ulrich
For decades of transformative design solutions across a broad range of optical products including photographic lenses, microscopy objectives, medical-imaging instrumentation, laser optics, metrology systems, and infrared optics.
SPIE Harrison H. Barrett Award in Medical Imaging: Elizabeth Krupinski
For pioneering work in medical-image perception, teleradiology, telepathology, and being among the first to carry out image-perception studies in the new domain of digital pathology.
SPIE Harold E. Edgerton Award in High-Speed Optics: Tara Fortier
For pioneering contributions to the development of frequency combs based on mode-locked lasers and their applications in metrology.
SPIE Dennis Gabor Award in Diffractive Optics: Aydogan Ozcan
For seminal contributions to holography, lens-free holographic microscopy, and computational imaging that democratize advanced measurement systems.
SPIE George W. Goddard Award in Space and Airborne Optics: John MacKenty
For leading the design, development, testing, and operations of the Wide-Field Camera 3 on the Hubble Space Telescope, and for pioneering contributions to multi-object spectroscopy from space.
SPIE G. G. Stokes Award in Optical Polarization: Miguel A. Alonso
For pioneering work in the mathematical description of unconventional and non-paraxial polarization states.
SPIE Chandra S. Vikram Award in Optical Metrology: Zeev Zalevsky
For key contributions to the invention of a laser-based, remote, nano-vibrations sensor with primary applications in biomedical sensing and diagnostics.
SPIE Frits Zernike Award for Microlithography: Anthony Yen
For three decades of contributions in advancing microlithography technology, including developing extreme-ultraviolet lithography for high-volume manufacture of semiconductor integrated circuits.
SPIE Diversity Outreach Award: Danuta Sampson
For outstanding achievements in international educational outreach and leadership of activities promoting public engagement and diversity in science.
SPIE Maria Goeppert Mayer Award in Photonics: Volker Sorger
For pioneering research and outstanding innovations in the research and development of photonic and nanophotonic devices and systems, and for community leadership.
SPIE Maiman Laser Award: Bo Gu
For critical innovations in industrial laser technology with numerous seminal and sustained contributions, and for being an accomplished laser-industry leader with widely recognized commercial success.
SPIE Early Career Achievement Award — Academic Focus: Carmelo Rosales-Guzmán
For significant and innovative technical contributions to the field of structured light and its applications, as well as for the promotion of science in developing countries.
SPIE Early Career Achievement Award — Industry/Government Focus: Fenglin Peng
For contributions enabling the first LCD-based VR product on the market, and for innovating a compact Pancake VR with better image quality, higher efficiency, and easier mass-production.
SPIE María J. Yzuel Educator Award: Alexis Spilman Vogt
For excellence in optics-technician and associate’s-degree education and training, and for being a superb strategic educator in addressing the needs of an underserved market.
SPIE Aden and Marjorie Meinel Technology Achievement Award: Wolfgang Fink
For pioneering, sustained contributions to the development of transformational opto-medical examination and device technologies, with particular focus on visual prostheses for the blind, ophthalmology, and tele-ophthalmology.
The complete listing of the SPIE Society Awards and recipients is available here.
About SPIE
SPIE, the international society for optics and photonics, brings engineers, scientists, students, and business professionals together to advance light-based science and technology. The Society, founded in 1955, connects and engages with our global constituency through industry-leading conferences and exhibitions; publications of conference proceedings, books, and journals in the SPIE Digital Library; and career-building opportunities. Over the past five years, SPIE has contributed more than $22 million to the international optics community through our advocacy and support, including scholarships, educational resources, travel grants, endowed gifts, and public-policy development. www.spie.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230110005929/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 10:22:00 CET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom